Ebewe Pharma Ges.m.b.H Nfg. KG Fareva Unterach GmbH

This is an anticancer drug used in the treatment of malignant tumors, particularly breast, stomach, and pancreatic cancer, as well as colorectal cancer.

Dosage form: solution for injection and infusion

ATC: L01BC02

The medicinal product is used in the treatment of neoplastic diseases, such as acute myeloid and lymphoblastic leukemias, leukemic infiltrates in the central nervous system, and non-Hodgkin lymphomas. It may also be used in treatment-resistant therapies or in the case of blast crisis in chronic myeloid leukemia.

Dosage form: solution for injection

ATC: L01BC01

The drug is used in the treatment of neoplastic diseases, such as acute leukemias (myeloid and lymphoblastic), leukemic infiltrates in the central nervous system, and non-Hodgkin lymphomas. In high doses, it is also used in cases of treatment-resistant lymphomas or leukemias and in blast crisis in chronic myeloid leukemia.

Dosage form: solution for infusion

ATC: L01BC01

The medicinal product is used in the treatment of advanced epithelial ovarian cancer (as first-line therapy or when other drugs have not worked) and in the treatment of small cell lung cancer.

Dosage form: solution for infusion, concentrate

ATC: L01XA02

The medicinal product is used to treat cancers, such as malignant tumors of the testis, ovary, cervix, bladder, lung, and squamous cell carcinoma of the head and neck. It may be administered alone or as part of chemotherapy.

Dosage form: solution for infusion, concentrate

ATC: L01XA01

The medicine is prescribed to treat breast cancer (advanced or early stage), lung cancer (non-small cell), prostate cancer, stomach cancer, and head and neck cancer.

Dosage form: solution for infusion, concentrate

ATC: L01CD02

The medicine is used, among others, in the treatment of soft tissue and bone sarcomas, Hodgkin's lymphoma, lymphomas, various types of leukemias, cancer of the thyroid, breast, ovary, bladder, and lungs, as well as multiple myeloma, and cancer of the stomach, pancreas, prostate, testis, and liver.

Dosage form: solution for infusion, concentrate

ATC: L01DB01

The medicinal product is used to treat many types of cancer, such as breast, ovarian, stomach, lung, head and neck, colon and rectal cancer, as well as in the treatment of multiple myeloma, non-Hodgkin lymphomas, acute leukemias, and certain bladder cancers.

Dosage form: solution for infusion, concentrate

ATC: L01DB03

The medicine is used to treat certain types of cancer in adults (including testicular cancer, small cell lung cancer, blood cancer, lymphatic system tumors, and reproductive system cancer) and in children (blood cancer and lymphatic system tumors).

Dosage form: solution for infusion, concentrate

ATC: L01CB01

The drug is used in the treatment of non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer.

Dosage form: solution for infusion, concentrate

ATC: L01BC05

The medicinal product is used in the treatment of malignant tumors (including leukemias, lymphomas, breast cancer, ovarian cancer, lung cancer, bone sarcomas) and in severe forms of psoriasis that do not respond to other treatment methods.

Dosage form: solution for injection

ATC: L01BA01

The medicinal product is used in the treatment of malignant tumors (e.g., leukemia, breast cancer, ovarian cancer, head and neck cancers, bone sarcomas) and in the treatment of severe forms of psoriasis that do not respond to other methods.

Dosage form: solution for infusion, concentrate

ATC: L01BA01

The medicine is used in the treatment of advanced breast cancer, non-Hodgkin lymphoma, acute myeloid leukemia, chronic myeloid leukemia (in blast crisis phase), pain associated with prostate cancer, and highly active relapsing multiple sclerosis.

Dosage form: solution for infusion, concentrate

ATC: L01DB07

The medicine is used to treat malignant tumors, such as mesothelioma and advanced-stage lung cancer.

Dosage form: solution for infusion, concentrate

ATC: L01BA04